MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 3, Issue , 2016, Pages 7-17

  Guedes, Joana R ^a,b   Santana, Isabel ^a,c,d   Cunha, Catarina ^d   Duro, Diana ^d   Almeida, Maria R ^a   Cardoso, Ana M ^a   de Lima, Maria C Pedroso ^a,e   Cardoso, Ana L ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; CCR2; Chemotaxis; Macrophages; MiRNAs; Monocytes; Phagocytosis; TREM2

Indexed keywords

AMYLOID BETA PROTEIN; CHEMOKINE RECEPTOR CCR2; MESSENGER RNA; MICRORNA; MICRORNA 128; MICRORNA 154; MICRORNA 155; MICRORNA 200B; MICRORNA 27B; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CCR2 GENE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CXCR4 GENE; FEMALE; GENE DISRUPTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE DYSREGULATION; INNATE IMMUNITY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MONOCYTE; PHAGOCYTOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREM2 GENE;

EID: 84956620147     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2015.11.004     Document Type: Article

References (47)

1. Lebson L., Nash K., Kamath S., Herber D., Carty N., Lee D.C., et al. Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice. J Neurosci 2010, 30:9651-9658.
2. Michaud J.P., Bellavance M.A., Prefontaine P., Rivest S. Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep 2013, 5:646-653.
3. Koronyo Y., Salumbides B.C., Sheyn J., Pelissier L., Li S., Ljubimov V., et al. Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer's disease. Brain 2015, 138:2399-2422.
4. El Khoury J., Toft M., Hickman S.E., Means T.K., Terada K., Geula C., et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 2007, 13:432-438.
5. Naert G., Rivest S. Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. Mol Med 2012, 18:297-313.
6. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., et al. TREM2 variants in Alzheimer's disease. N Engl J Med 2013, 368:117-127.
7. Fiala M., Lin J., Ringman J., Kermani-Arab V., Tsao G., Patel A., et al. Ineffective phagocytosis of amyloid-ß by macrophages of Alzheimer's disease patients. J Alzheimers Dis 2005, 7:221-232.
8. Naert G., Rivest S. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. J Neurosci 2011, 31:6208-6220.
9. Wang Y., Cella M., Mallinson K., Ulrich J.D., Young K.L., Robinette M.L., et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 2015, 160:1061-1071.
10. Jay T.R., Miller C.M., Cheng P.J., Graham L.C., Bemiller S., Broihier M.L., et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med 2015, 212:287-295.
11. Hickman S.E., Kingery N.D., Ohsumi T.K., Borowsky M.L., Wang L.C., Means T.K., et al. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 2013, 16:1896-1905.
12. Cardoso A.L., Guedes J.R., Pereira de Almeida L., Pedroso de Lima M.C. miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 2012, 135:73-88.
13. Guedes J.R., Custodia C.M., Silva R.J., de Almeida L.P., Pedroso de Lima M.C., Cardoso A.L. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model. Hum Mol Genet 2014, 23:6286-6301.
14. Butovsky O., Siddiqui S., Gabriely G., Lanser A.J., Dake B., Murugaiyan G., et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 2012, 122:3063-3087.
15. Kleinberger G., Yamanishi Y., Suarez-Calvet M., Czirr E., Lohmann E., Cuyvers E., et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 2014, 6:243ra86.
16. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". J Psychiatr Res 1975, 12:189-198.
17. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699.
18. Mohs R.C., Rosen W.G., Davis K.L. The Alzheimer's disease assessment scale: An instrument for assessing treatment efficacy. Psychopharmacol Bull 1983, 19:448-450.
19. Guerreiro M. Contributo da Neuropsicologia para o estudo das demências 1998, (Unpublished doctoral dissertation), University of Lisbon, Lisbon.
20. Morris J.C. The clinical dementia rating (CDR): Current version and scoring rules. Neurology 1993, 43:2412-2414.
21. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1983, 17:37-49.
22. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:270-279.
23. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256:183-194.
24. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:263-269.
25. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260.
26. Frevert C.W., Wong V.A., Goodman R.B., Goodwin R., Martin T.R. Rapid fluorescence-based measurement of neutrophil migration in vitro. J Immunol Methods 1998, 213:41-52.
27. Resende R., Ferreiro E., Pereira C., Resende de Oliveira C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 2008, 155:725-737.
28. Volpe S., Cameroni E., Moepps B., Thelen S., Apuzzo T., Thelen M. CCR2 acts as scavenger for CCL2 during monocyte chemotaxis. PLoS One 2012, 7:e37208.
29. Baik S.H., Cha M.Y., Hyun Y.M., Cho H., Hamza B., Kim D.K., et al. Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Neurobiol Aging 2014, 35:1286-1292.
30. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009, 41:1088-1093.
31. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011, 43:429-435.
32. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009, 41:1094-1099.
33. Wunderlich P., Glebov K., Kemmerling N., Tien N.T., Neumann H., Walter J. Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and gamma-secretase-dependent intramembranous cleavage. J Biol Chem 2013, 288:33027-33036.
34. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011, 44:839-847.
35. Lu M.H., Li C.Z., Hu C.J., Fan Y.H., Wang S.M., Wu Y.Y., et al. microRNA-27b suppresses mouse MSC migration to the liver by targeting SDF-1alphain vitro. Biochem Biophys Res Commun 2012, 421:389-395.
36. Freilich R.W., Woodbury M.E., Ikezu T. Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. PLoS One 2013, 8:e79416.
37. Naert G., Rivest S. A deficiency in CCR2+ monocytes: The hidden side of Alzheimer's disease. J Mol Cell Biol 2013, 5:284-293.
38. Mahad D., Callahan M.K., Williams K.A., Ubogu E.E., Kivisakk P., Tucky B., et al. Modulating CCR2 and CCL2 at the blood-brain barrier: Relevance for multiple sclerosis pathogenesis. Brain 2006, 129:212-223.
39. Galimberti D., Fenoglio C., Lovati C., Venturelli E., Guidi I., Corra B., et al. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol Aging 2006, 27:1763-1768.
40. Reale M., Iarlori C., Feliciani C., Gambi D. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. J Alzheimers Dis 2008, 14:147-159.
41. Pellicano M., Bulati M., Buffa S., Barbagallo M., Di Prima A., Misiano G., et al. Systemic immune responses in Alzheimer's disease: In vitro mononuclear cell activation and cytokine production. J Alzheimers Dis 2010, 21:181-192.
42. Parachikova A., Cotman C.W. Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease. Neurobiol Dis 2007, 28:143-153.
43. Krabbe G., Halle A., Matyash V., Rinnenthal J.L., Eom G.D., Bernhardt U., et al. Functional impairment of microglia coincides with beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 2013, 8:e60921.
44. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
45. Hu N., Tan M.S., Yu J.T., Sun L., Tan L., Wang Y.L., et al. Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. J Alzheimers Dis 2014, 38:497-501.
46. Tiribuzi R., Crispoltoni L., Porcellati S., Di Lullo M., Florenzano F., Pirro M., et al. miR128 up-regulation correlates with impaired amyloid beta(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiol Aging 2014, 35:345-356.
47. Fiala M., Liu P.T., Espinosa-Jeffrey A., Rosenthal M.J., Bernard G., Ringman J.M., et al. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci U S A 2007, 104:12849-12854.